This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Feb;165(3):19.

doi: 10.1007/s15006-023-2351-z.

Hyperkaliämie unter RAASi: Therapiestopp ist nicht die Lösung!

[Article in German]

Elke Oberhofer¹

Affiliations

PMID: 36759456
DOI: 10.1007/s15006-023-2351-z

Comment

Hyperkaliämie unter RAASi: Therapiestopp ist nicht die Lösung!

[Article in German]

Elke Oberhofer. MMW Fortschr Med. 2023 Feb.

. 2023 Feb;165(3):19.

doi: 10.1007/s15006-023-2351-z.

Author

Elke Oberhofer¹

Affiliation

¹ Springer Medizin Verlag GmbH, Aschauer Str. 30, 81549, München, Germany.

PMID: 36759456
DOI: 10.1007/s15006-023-2351-z

No abstract available

PubMed Disclaimer

Comment on

Outcomes in patients with cardiometabolic disease who develop hyperkalemia while treated with a renin-angiotensin-aldosterone system inhibitor.
Johnson M, Morrison FJ, McMahon G, Su M, Turchin A. Johnson M, et al. Am Heart J. 2023 Apr;258:49-59. doi: 10.1016/j.ahj.2023.01.002. Epub 2023 Jan 13. Am Heart J. 2023. PMID: 36642227

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer